Skip to content
S1720Senate2023-2024 SessionSame asA9188

Ban Tianeptine Sodium

Official title

“Adds tianeptine sodium to the list of Schedule II of controlled substances”

Sponsor James SkoufisSD-42Affects Health
Status
In Senate Committee
Health
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill adds tianeptine sodium to New York’s schedule II list of controlled substances.

Why it matters

  1. Classifying tianeptine sodium as a Schedule II controlled substance would significantly restrict its availability, meaning it could only be legally prescribed and dispensed under strict regulations, similar to other drugs with high abuse potential but accepted medical uses.

  2. The measure is a response to increasing concerns about misuse and addiction associated with tianeptine, which is often marketed online as a 'supplement' but has been linked to opioid-like effects and withdrawal symptoms.

  3. Pharmacies, healthcare providers, and law enforcement would need to update their practices and monitoring systems to track tianeptine sodium, potentially reducing illicit sales and unregulated access in New York.

  4. Making tianeptine sodium a controlled substance may impact individuals who currently use it (legally or illegally), possibly prompting some to seek medical oversight, addiction treatment, or alternative therapies.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Ban Tianeptine Sodium

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
James Skoufis

Senator · Senate District 42

Chair, Investigations And Government Operations

No co-sponsors yet.

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A9188Assembly

Ban Tianeptine Sodium Sales

In Assembly Committee · Health · Sponsor Edward Braunstein

Impact 6 · Moderate0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

1720

2023-2024 Regular Sessions

IN SENATE

January 13, 2023

Introduced by Sen. SKOUFIS -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision (e) of schedule II of section 3306 of the public health law is amended by adding a new paragraph 5 to read as follows:

(5) Tianeptine sodium.

§ 2. This act shall take effect on the ninetieth day after it shall have become a law.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD04681-01-3

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances

Purpose

Adds tianeptine sodium to the list of schedule II of controlled substances

Summary of provisions

Section 1: Subdivision (e) of schedule II of Section 3306 of the Public Health Law is amended by adding a new paragraph 5.

Section 2: sets forth the effective date.

Justification

Tianeptine sodium is an antidepressant that has not been approved by the United States Food and Drug Administration. It has also not been approved for medical use in Australia, Canada and the United Kingdom. However, it is still available for purchase online and is marketed as a supplement or research chemical. Tianeptine sodium is often abused in high doses to simulate opioid like highs and can lead to addiction coupled with withdrawal symptoms.

According to the Associated Press, Michigan became the first state to ban tianeptine sodium "after a spate of gruesome overdoses related to tianeptine sodium scoured the Midland and Saginaw area in 2017." Addi- tionally, the U.S. Centers for Disease Control and Prevention's Morbidi- ty and Mortality Weekly Report in August, 2018, reported there were 207 poison control center calls related to tianeptine sodium from 20142018, compared to only 11 calls in the previous 14 years.

The Associated Press reported that a substance abuse recovery coach testified before the Michigan State Senate about how her "addiction to tianeptine sodium affected her while weaning herself off heroin a proc- ess she said was far less horrific than tianeptine withdrawal. I could not get out of bed, go to work, have a normal functioning day without (tianeptine sodium) in my life. I am convinced that (it) is the next epidemic."

Legislative history

Senate

2020 - S8023, Referred to Health

2021-2022- S1776, Referred to Health

Assembly

2020- A7750, Referred to Health

2021-2022- A344, Referred to Health

Fiscal implications

None.

Effective date

This act shall take effect on the ninetieth day after it shall become law.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.